Table 5.
Positive predictive value of three different FOBTs, Group Health, Washington State 2010-2012a
| OC-Auto® | InSure® | Hemoccult SENSA® | |
|---|---|---|---|
| FOBT positive, No. | 16 | 21 | 14 |
| Followed-up by colonoscopy, No. | 12 | 21 | 14 |
| High-risk finding per modified USMSTF guidelinesa | |||
| No. | 4 | 5 | 4 |
| PPV (95% confidence interval) | 33% (10%-65%) | 24% (8%-47%) | 29% (8%-58%) |
| High-risk finding per adapted USMSTF guidelinesa, excluding sessile adenomas removed piecemeal | |||
| No. | 2 | 5 | 2 |
| PPV (95% confidence interval) | 17% (2%-48%) | 24% (8%-47%) | 14% (2%-42%) |
| Any adenoma or cancerb | |||
| No. | 7 | 8 | 7 |
| PPV (95% confidence interval) | 58% (28%-85%) | 38% (18%-62%) | 50% (23%-77%) |
Abbreviations: FOBT, fecal occult blood test; PPV: positive predictive value; USMSTF: United States Multi-Society Task Force.
USMSTF defines high risk as cancer, ≥3 adenomas, adenoma >1 cm (we used ≥1 cm), adenoma with villous features, adenoma with high-grade dysplasia, or sessile adenomas removed piecemeal.
All were adenomas. PPVs were computed based on test returned rather than randomization group. Three of the participants assigned to the OC-Auto FIT test had completed a standard Group Health gFOBT instead of the study FIT.